Skip to main content

Table 4 Significant biological pathways represented in the set of intersection genes between regions.

From: Analysis of Alzheimer's disease severity across brain regions by topological analysis of gene co-expression networks

Region comparison

Pathways

p value (FDR = 0.05)

EC-HIP

NF-AT signaling in Cardiac Hypertrophy

6.711e-7

 

Role of heterochromatin protein 1 (HP1) family in transcriptional silencing

3.309e-6

 

NGF activation of NF-kB

9.559e-6

EC-MTG

Cytoskeleton remodelling Neurofilaments

3.564e-8

 

Oxidative phosphorylation

1.314e-6

 

Development-A2B receptor: action via G-protein alpha s

2.328e-5

EC-PCC

Role of heterochromatin protein 1 (HP1) family in transcriptional silencing

5.846e-7

 

Cytoskeleton remodelling-TGF, WNT and cytoskeletal remodelling

7.951e-7

 

Chemokines and adhesion

5.369e-6

HIP-MTG

Oxidative phosphorylation

1.615e-24

 

Ubiquinone metabolism

2.971e-12

 

Clathrin-coated vesicle cycle

3.490e-8

HIP-PCC

Oxidative phosphorylation

6.858e-13

 

TGF, WNT and cytoskeletal remodelling

1.037e-7

 

Role of 14-3-3 proteins in cell cycle regulation

2.839e-7

PCC-MTG

Oxidative phosphorylation

1.003e-32

 

Ubiquinone metabolism

3.485e-16

 

Clathrin-coated vesicle cycle

1.789e-8

  1. Identification of differentially expressed (DE) genes was carried out by comparing AD affected and unaffected samples within a region. The intersection of the DE genes between two regions was extracted and significant pathways identified (See Table 2, column 2).